
Granules India Limited has informed the Exchange regarding a press release dated September 30, 2023, titled "Granules India Limited Received ANDA Approval for Losartan and Hydrochlorothiazide Tablets".
Filed with NSE ·

Granules India Limited has informed the Exchange regarding a press release dated September 30, 2023, titled "Granules India Limited Received ANDA Approval for Losartan and Hydrochlorothiazide Tablets".
6ix hasn’t read this filing yet.
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India